Vaxcyte Inc (PCVX)
Healthcare
Biotechnology
53.50 $
-1.0%
vs. previous close
Closing price · As of: 3. Aug 2026
Vaxcyte Inc (PCVX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -656 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 0.0 | -30 | -47 | -47 | -121 | -171 | -297 | -453 | -656 | |
| 0.0 | 1.0 | 1.2 | 1.4 | 3.5 | 9.5 | 10 | 16 | 25 | |
| 0.0 | 0.7 | 1.2 | 5.4 | 11 | 24 | 49 | 85 | 139 | |
| -0.1 | -3.9 | -2.0 | 5.9 | 12 | 31 | – | – | – | |
| 0.0 | 1.9 | 3.9 | 35 | -37 | 13 | 81 | -55 | -3.5 | |
| 0.0 | 1.8 | 1.2 | 1.2 | 6.6 | 5.8 | 68 | 22 | 14 | |
| 0.0 | -1.8 | -1.2 | -1.1 | -212 | 75 | -773 | -2,006 | 437 | |
| – | – | – | 0.4 | – | – | – | – | – | |
| 44 | 62 | 43 | 0.4 | 0.9 | 1.0 | 2.0 | – | – | |
| -0.2 | -0.3 | -0.3 | -0.1 | 0.0 | 0.0 | – | – | – | |
| 0.0 | 62 | 42 | 375 | 18 | 862 | 640 | 2,449 | 2.0 | |
| 0.0 | 30 | -7.1 | 327 | -316 | 766 | -437 | -9.4 | -214 | |
| 0.0 | -32 | -48 | -48 | -128 | -176 | -365 | -475 | -669 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.